Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patient expectations

- PMLiVE

All change – how untangling human behaviour can encourage better health

Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence

- PMLiVE

Solving healthcare problems

What needs to change?

- PMLiVE

New data from Moderna supports COVID boosters

Waning immunity from its mRNA jab “support benefit” of a booster shot, says Moderna, while international scientists publish plea for evidence over politics

- PMLiVE

$47.5m research centre to seek genetic insights into disease

The Novo Nordisk Foundation and Broad Institute have teamed up to mine genetic data for disease insights and help develop the next generation of researchers

- PMLiVE

Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards

The event took place online through an interactive events platform on 16 September

- PMLiVE

Health For All

By Claire Knapp and Cath Brassington-Richards

Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost

Lydia Zeller, CEO at Kiio, explores digital therapeutics, healthcare innovation, and Kiio’s innovative and personalized solutions for musculoskeletal (MSK) pain. She also shares her key leadership lessons and predictions for...

Impetus Digital

Accelerating Drug Development Timelines with Big Data Analytics

Barış Erdoğan, CEO of Clinerion, shares how medical data informatics and real-world EHR data can be used to improve the efficiency and effectiveness of patient searches, identification, and recruitment; clinical...

Impetus Digital

A Lucid Group Thirsty Thursday Special: Beautiful Rejects

Last week, we waved goodbye to the post-holiday blues by welcoming back our legendary Thirsty Thursday sessions! Hosted by the Innovation Champions in Middlesex House, London, and broadcast to all...

Lucid Group Communications Limited

EU flag

EU “still interested” in Valneva COVID vaccine despite UK snub

Negotiations between Valneva and the EU are “ongoing and advanced”, with its vaccine candidate VLA2001 touted as a potential booster shot in France

regeneron headquarters

US orders 1.4 million more doses of Regeneron antibody cocktail

The new $2.9bn order increases the amount of Regeneron’s anti-COVID REGEN-COV purchased by the US government to nearly 3 million doses

- PMLiVE

Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions

By Christina Jackson and Cat Barnett

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links